Skip to content

Prediction Model for Atrial Arrhythmias After Dual-Chamber Pacemaker Implantation

Construction and Validation of a Prediction Model for Atrial Arrhythmias After Dual-Chamber Pacemaker Implantation Based on Multi-Parameter Fusion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121131
Enrollment
Unknown
Registered
2026-03-26
Start date
2026-03-26
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial arrhythmias

Interventions

Observation group:None

Sponsors

Beijing Haidian Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old; 2.First implantation of a dual-chamber pacemaker due to sick sinus syndrome or atrioventricular block at Beijing Haidian Hospital; 3.No definitive preoperative evidence of atrial arrhythmias including atrial flutter, atrial fibrillation, or atrial tachycardia; 4.The pacemaker Automatic Mode Switch (AMS) function is enabled by default and can detect and record atrial arrhythmia events; 5.Complete clinical data and pacemaker follow-up data are available.

Exclusion criteria

Exclusion criteria: 1.Complicated with valvular heart disease, congenital heart disease, cor pulmonale, cardiomyopathy, hyperthyroidism, malignant tumor or other diseases; 2.Life expectancy less than 6 months; 3.Previous history of radiofrequency ablation, pulsed field ablation, cryoballoon ablation or other procedures for atrial fibrillation or atrial flutter; 4.Requirement of antiarrhythmic drugs for other types of arrhythmias during the follow-up period; 5.Severe loss of clinical data and unavailability of valid follow-up data.

Design outcomes

Primary

MeasureTime frame
Occurrence of AHRE within 18 months after operation;

Secondary

MeasureTime frame
The composite endpoint of severe clinical consequences occurred within 18 months after the procedure, including the initiation of drug therapy for atrial arrhythmia, ischemic stroke or transient ischemic attack, rehospitalization for heart failure, and death;

Countries

China

Contacts

Public ContactZhang Qing

Beijing Haidian Hospital

17331623785@163.com+86 10 82693140

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026